TRAVERE THERAPEUTICS, INC. Common Unit, Issued
TRAVERE THERAPEUTICS, INC. (TVTX) had Common Unit, Issued of 401.05 thousand shares as of 2014-06-30, per its 10-Q filed 2014-08-14.
Discontinued › Balance Sheet › Equity
us-gaap:CommonUnitIssued · last filed 2014-08-14
- 2014-06-30: Common Unit, Issued 401.05K shares.
| Period end | Common Unit, Issued |
|---|---|
| 2014-06-30 | 401.05K shares 10-Q · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |